Bedrijfsoverzicht
INLIF Limited, operating through its various subsidiaries, is dedicated to the research, development, manufacture, and sale of injection molding machine-dedicated manipulator arms marketed under the iNLIF brand within the People's Republic of China. The enterprise functions specifically within the Industrials sector and the Specialty Industrial Machinery industry, focusing on the production of transverse single and double-axis manipulator arms. Currently, the company maintains a market capitalization of $53.22M and employs a workforce of 156 individuals to support its manufacturing operations. With an annual revenue of $18.41M, the firm operates as a small-cap entity, a position indicated by its market valuation which suggests it is a niche player rather than a large-scale industrial conglomerate. The revenue figure of $18.41M relative to the $53.22M market cap highlights a significant disparity between sales volume and market valuation, characteristic of companies in early-stage growth or those facing specific sector headwinds.
Financiële gezondheid
The company reported a revenue of $18.41M over the trailing twelve months, yet it simultaneously posted a net income of -$5,446,252 and an EBITDA of -$5,489,902. The substantial gap between the positive revenue of $18.41M and the negative net income reveals a cost structure where operating expenses and costs of goods sold significantly exceed total sales revenue, resulting in a loss-making environment. Despite the net losses, the company generated positive free cash flow of $1.10M, which provides a degree of financial flexibility by allowing the business to fund operations and potentially service debt without immediate external financing. This positive cash flow contrasts sharply with the negative earnings, suggesting that non-cash expenses or timing differences in working capital management are impacting the bottom line. The gross margin stands at 23.3%, indicating that the company retains nearly a quarter of revenue after direct production costs, while the operating margin of -46.1% and profit margin of -29.6% demonstrate severe inefficiencies in covering overhead and general administrative expenses. The balance sheet shows the company holds $6.72M in cash against $4.97M in debt, yet the debt-to-equity ratio is reported at 30.82, a metric that requires careful interpretation given the negative equity base implied by the financial losses. The current ratio of 2.11 indicates that the company possesses more than double the current assets needed to cover its short-term liabilities, suggesting adequate short-term liquidity to meet immediate obligations. Furthermore, the return on equity is -41.3% and the return on assets is -16.8%, metrics that reveal that management is currently not generating value for shareholders or utilizing assets profitably, as both return measures are deeply negative.
Waarderingsbeoordeling
The trailing twelve-month P/E ratio and forward P/E ratio are both listed as N/A due to the company's reported net losses, implying that traditional earnings-based valuation methods are currently inapplicable. The price-to-book ratio is 0.28, which indicates that the market values the company at less than one-third of its book value, suggesting a significant discount rather than a market premium over the net asset value. The price-to-sales ratio is 2.89, while the EV/EBITDA stands at -9.38; these alternative valuation metrics suggest that the market is pricing the stock based on revenue multiples rather than profitability, likely due to the negative earnings profile. The 52-week high is $28.00 and the 52-week low is $3.47, placing the current trading price significantly below the high and near the lower end of the historical range observed over the past year. The beta value is listed as N/A, meaning that standard volatility data relative to the broader market is not available or disclosed for this specific security in the current dataset.
Growth & Income
The company experienced a year-over-year revenue growth of -10.2%, while the earnings growth is N/A due to the negative earnings base. Since earnings are negative, a comparison of growth rates between earnings and revenue is not mathematically possible, but the contraction in revenue suggests a shrinking top line rather than an expansion. As a non-dividend payer, the company reports a dividend yield of N/A and a payout ratio of 0.0%, indicating that the firm retains all its earnings or cash flow rather than distributing them to shareholders. Consequently, the company reinvests its generated free cash flow of $1.10M back into its operations, research, or manufacturing capacity to attempt a turnaround in profitability. The overall growth and income profile is characterized by declining revenue, negative profitability, and a lack of dividend distribution, presenting a scenario where capital preservation is currently more critical than income generation for investors monitoring the stock.